Rocketman
Long

600276: JiangSu HengRui

SSE:600276   JIANGSU HENGRUI MEDICINE CO.,LTD.
Pharmaceuticals have done well in China over the long-term for many years. Given the quality of JiangSu HengRui and its perpetual growth, there is no reason why this trend should abate over the long haul. This stock is immune to a trade war, yet not immune to business cycle risks, which has caused turbulence for weeks to months before.

I am a little late to publish this article, but it follows up on a previous article that I wrote and posted regarding China's Roaring 2020s.
Comment: Just more opportunity to buy at a favorable price:
Comment:
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing TradingView Coins My Support Tickets Get Help Ideas Published Followers Following Private Messages Chat Sign Out